L-Asparaginase (ASNase) is a vital component of the first line treatment of acute
lymphoblastic leukemia (ALL), an aggressive type of blood cancer expected to afflict over …

Abstract l-asparaginase (EC 3.5. 1.1) is an important enzyme that has been purified and
characterized for over decades to study and evaluate its anti-carcinogenic activity against …

Abstract l-asparaginase (l-asparagine amino hydrolase, EC 3.5. 1.1) is an enzyme clinically
accepted as an antitumor agent to treat acute lymphoblastic leukemia and lymphosarcoma …

Abstract l-Asparaginase is one of the main drugs used in the treatment of acute
lymphoblastic leukemia (ALL), a commonly diagnosed pediatric cancer. Although several …

There is an increasing interest in using l-asparaginase in medical fields and food processing
industries. Enzyme immobilization is an attractive field to improve l-asparaginase activity …

Asparaginase is an important antileukemic agent extensively used worldwide but the
intrinsic glutaminase activity of this enzymatic drug is responsible for serious life threatening …

Enzymes today play a predominant role in the pharmaceutical industries due to their ability
to efficiently and selectively catalyze biochemical reactions in living systems. Since the …

Abstract L-Asparaginase (L-ASNase EC 3.5. 1.1) is considered as an important
biopharmaceutical drug enzyme in the treatment of childhood acute lymphoblastic leukemia …

Background L-asparaginase (ASNase) has played a key role in the management of acute
lymphoblastic leukaemia (ALL). As an amidohydrolase, it catalyzes the hydrolysis of L …

There are two major applications of l-asparaginase (L-ASNase): leukemia therapy and the
food industry. Especially, its chemotherapeutic effect has attracted interest from the scientific …